Bryan Liptzin is a Director of Global Quality and Compliance at Amgen, Inc. He has been with Amgen since 1995, and has held a variety of roles within Regulatory Affairs and Quality. He recently managed the global regulatory approval process for Amgen’s five year, $5 Billion expansion in Puerto Rico. Prior to joining Amgen, he managed the QC Microbiology department at CellPro, Inc, and worked in various QC roles at Serono, and Bristol Meyers. He is active in the Parenteral Drug Association (PDA) and the Biotech Industry Organization (BIO), and helped develop the minority fellows program at BIO which provides mentoring and opportunities to underrepresented groups within our industry. Liptzin received a degree in Biology from Grinnell College in 1984.